554 filings
Page 2 of 28
8-K
6k8afi 7z
10 Aug 23
ProPhase Labs Announces Financial Results
8:00am
8-K
qv9pkhscqjy2lr8lovm
29 Jun 23
Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
8:05am
8-K
5k62fr9bc7yt9qk
22 Jun 23
Regulation FD Disclosure
8:35am
8-K
eq1doeh9mz
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
kstsav8j 7amtznhq1pt
20 Jun 23
Departure of Directors or Certain Officers
4:15pm
8-K
qzl y16eau
11 May 23
ProPhase Labs Announces Financial Results
8:10am
ARS
sa0t2r
27 Apr 23
Annual report to shareholders
8:05am
8-K
lczp611wvyx13fdu4wy
25 Apr 23
Regulation FD Disclosure
8:20am
8-K
b4z rxuct
6 Apr 23
Departure of Directors or Certain Officers
4:15pm
8-K
gxjbnfobp0qoav wv3y
28 Mar 23
ProPhase Labs Announces Record Financial Results
8:05am
8-K
jm9652r6
15 Mar 23
ProPhase Labs Announces New $6 Million Stock Repurchase Program
8:05am
8-K
9s8u76 y5
1 Mar 23
Company in Early Stages of Exploring Development for Commercialization in Other Countries
8:05am
8-K
q1jo0t9nq yzfu6
22 Feb 23
Goal to launch commercially in Q4 2023
8:05am
8-K
f76r3 int
15 Feb 23
ProPhase Labs Announces Plans for Major Expansion of its Pharmaloz Manufacturing, Inc. Subsidiary to Meet Growing Demand
8:05am
8-K
9xccoyze2c9w
6 Feb 23
ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy
9:29am
8-K
5fas658 j5m
30 Jan 23
Entry into a Material Definitive Agreement
4:30pm